Market Outlook
The factors influencing the growth of the global compression therapy market are the increasing occurrence of sports injuries and accidents, and the growth in the target patient populace. Additionally, the technological advancements in the healthcare industry, along with the growing awareness regarding the advantages of compression therapy among consumers, is also expected to impact the global market positively. Moreover, the advancements in the textiles and garment industry have led to the manufacturing of better-quality bandages and compression stockings. This has increased patient comfort and contributed to a rise in the patient population.
On the other hand, inadequate reimbursement government policies in developing countries, low patient compliance for compression garments, adoption of substitute therapies for certain target indications and the lack of broadly accepted standards for compression products are likely to hinder the market growth for compression therapy over the review period.
Key Players
The significant market players identified in the global compression therapy market are 3M, Bio Compression Systems, Inc., BSN Medical, Cardinal Health, Inc., Convatec Inc., DJO Global Inc., Getinge AB, Juzo, Medtronic PLC, Medi GmbH & Co. Kg, Paul Hartmann AG, Sigvaris, Sanyleg S.R.L., Smith & Nephew PLC., Tactile Medical, and others.
Segmentation Analysis
Segmental analysis
The market for compression therapy is segmented on the basis of technique, product, and application.
The global compression therapy market is bifurcated into dynamic compression therapy and static compression therapy.
The multiple products available in the global compression therapy market are compression braces, compression garments, and compression pumps. The compression garments segment is sub-segmented into compression bandages and wraps, compression stockings, and others.
The applications of compression therapy are deep vein thrombosis treatment, leg ulcer treatment, lymphedema treatment, varicose vein treatment, and others.
Regional Analysis
Based on the region, the global market for compression therapy is studied in Asia Pacific, North America, Europe, and the Middle East and Africa.
North America is the largest region in the global compression therapy market and is estimated to retain its leading market share over the assessment period. This is attributed to the established healthcare sector in the region, the presence of leading market players, and the early adoption of technological advancements in the medical industry. The presence of a thriving sports industry, especially baseball, soccer, rugby, and basketball, contributes to the demand in the market owing to the occurrence of sports injuries and accidents.
Europe is accounted for the second-largest market share in the global compression therapy market over the evaluation period. This is credited to the rising investment towards the healthcare sector by the government and adoption of advanced medical devices and techniques in the region. The stable economy ensures the availability of a high per capita income, which enables consumers to afford modern medical facilities. The presence of the sports industry for cricket and sports injuries and medical conditions is likely to contribute to the market share of this region over the review period.
The Asia Pacific has been assessed as the fastest-growing region in the global compression therapy market over the forecast period. This is attributed to the rising development of the healthcare industry and the adoption of advanced technologies in the medical sector. Furthermore, the augment in the sports industry, especially cricket, hockey, among others, has risen the patient population. Government initiatives in developing economies such as India, China, and others towards the adoption of advanced medical facilities and research and development in healthcare is also expected to contribute substantially towards market growth over the assessment period.
The middle east and Africa region are likely to acquire the smallest market share over the evaluation period owing to the lack of a skilled workforce, weak healthcare sector, among others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research FutureOffice No. 528, Amanora ChambersMagarpatta Road, Hadapsar,Pune - 411028Maharashtra, IndiaPhone: +16468459312Email: [email protected]
Global Military Communications Market was around US$ 30.0 Bn in 2017 and is expected to reach US$ 35.64 Bn by 2026, at a CAGR of around 4.75% in the forecast period.
Increase in procurement of military communication solutions because of rise in disputes among countries across the world, growing concerns that are related to the security of military communications, along with the need for modernizing and replacing aging communication equipment are some of the major factors that are driving the global military communications market.
Interoperability issues however may restrain the growth of the military communications market across the globe.
Communication solutions interoperability associated with army together with the collaboration between different defense agencies or departments is very essential for effective communications.
Thus, spectrum allocation for delivering information, rapidly changing technologies, changing stature of operations, together with investment issues hampering the operability in military communications are a few other key restraints of the military communications market.
Based on application, the situational awareness segment of the military communications market is expected to grow at one of the highest rate during the current forecast period.
Factors such as the growing incidence of urolithiasis and technological advancements in lithotripsy devices are driving the growth of this market.The report Lithotripsy Devices Market is expected to reach USD 1.76 Billion by 2023 from USD 1.41 Billion in 2018, at a CAGR of 4.5%.Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=29769904Market Segmentation:- By type, the lithotripsy devices market is classified into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices.
In 2017, the extracorporeal shock wave lithotripsy devices segment accounted for the largest share of the market.
ESWL is the least invasive of all stone treatments and is considered the treatment modality of choice for a majority of urinary stones.On the basis of applications, the lithotripsy devices market is categorized into kidney stones, ureteral stones, pancreatic stones, and bile duct stones.
In 2017, the kidney stones segment accounted for the largest share of the market.
The increasing incidence of kidney stones and the recurrence of these stones over a period of time are the key factors driving the growth of this segment.On the basis of end user, the lithotripsy devices market is categorized into hospitals, ambulatory surgical centers, and other end users.
In 2017, the hospitals segment accounted for the largest share of the global lithotripsy devices market.Target Audience for this Report:-Manufacturers and vendors of lithotripsy devicesResearch associations related to surgeriesVarious research and consulting firmsDistributors of lithotripsy devicesGovernment bodiesVenture capitalistsRegional Analysis:-Based on region, the lithotripsy devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).
This report also researches and evaluates the impact of Covid-19 outbreak on the Mild Steel Hacksaw Blade industry, involving potential opportunity and challenges, drivers and risks.
We present the impact assessment of Covid-19 effects on Mild Steel Hacksaw Blade and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.
).GLOBAL INFO RESEARCH added a new research report to its exhaustive repository.
The report studies the ongoing political scenarios that are expected to dictate the pricing and import and export in the global Mild Steel Hacksaw Blade market.
Furthermore, it also explains the lucrative opportunities present in the overall market that players can focus on to make their mark.Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/577308/mild-steel-hacksaw-bladeThe following Companies as the Key Players in the Global Mild Steel Hacksaw Blade Market Research Report:Apex Tool GroupKlein ToolsMilwaukee ToolC.
)Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)The scope of the Report: The research report on Mild Steel Hacksaw Blade includes segmentation of the market.
To order this detailed 310+ page report, please visit this link Key Inclusions A detailed assessment of the current market landscape of therapeutics targeting STING pathway, based on several parameters, such as type of STING modulator (agonist or antagonist), type of molecule (small molecules, cyclic dinucleotides, non-nucleotides, biologics and others), phase of development (discovery, preclinical and clinical), target therapeutic area(s), type of therapy (monotherapy and combination therapy), route of administration (intratumoral, intravenous and others), and line of treatment (last line, second line or greater and first line or greater).
The chapter also features an analysis of the developer landscape (including information on year of establishment, company size, geography and most active players).
Further the chapter includes an analysis on the clinical trials focused on STING, along with information on parameters, such as recruitment status, study design and clinical endpoints.A detailed chapter highlighting various technology platforms that are being actively used for the development of STING modulators and analysis based on several parameters, such as type of modulator (agonist or antagonist), type of molecule (small molecules, cyclic dinucleotides, non-nucleotides, live biotherapeutics, nanoparticles and synthetic peptides), and analysis based on technology developer landscape (including information on year of establishment, company size and geography).Elaborate profiles of key players that are engaged in the development of therapeutics targeting STING pathway (shortlisted on the basis of phase of development of pipeline products), featuring a brief overview of the company, its financial information (if available), detailed descriptions of their respective lead drug candidates, recent developments and an informed future outlook.
Additionally, each drug profile features information on the type of drug, route of administration, target indications and current status of development.Tabulated profiles of industry players (shortlisted on the basis of the antagonist in pipeline products), featuring details on the innovator company (such as year of establishment, location of headquarters, number of employees, key members of the executive team and recent developments), along with descriptions of their respective drug candidates.A study on various grants that have been awarded to research institutes engaged in projects related to STING pathway, during the period 2015 - Q1 2020, based on multiple parameters, such as number of grants awarded, amount awarded, funding institute, support period, funding mechanism, type of grant application, grant activity code, most popular NIH department, type of recipient organization, regional distribution, most popular recipient organization(s), prominent project leader(s) and study section.
It also includes an analysis of on grant attractiveness.An analysis of big pharma players engaged in the development of therapeutics targeting STING pathway, based on several parameters, such as portfolio diversity, type of molecule, phase of development, therapeutic area(s), type of therapy and route of administration.
In addition, the chapter features a benchmarking analysis of the aforementioned players.An analysis of the start-ups / small players (established in the last ten years, less than 50 employees) engaged in the development of therapeutics targeting STING pathway, based on several relevant parameters, such as portfolio diversity, type of molecule, phase of development, therapeutic area, funding received, number of investors, type of funding, partnership activity, number of patents filed, grants received, and start-up health indexing.A detailed publication analysis of more than 300 peer-reviewed, scientific articles that have been published during the period 2019 - Q1 2020, highlighting the research focus within the industry.
Factors driving the growth of this market include the rising incidence of target indications; availability of funding for stem cell research; technological advancements in stem cell research instruments; and growth of end-use industries.The stem cell assay market was valued at USD 660.9 Million in 2017 and is expected to reach USD 1,978.7 Million by 2023, at a CAGR of 20.1%.Selected Market Dynamics in Stem Cell Assay Market Growth of end-use industries The growth of the stem cell assays market corresponds with that of the biotechnology and biopharmaceutical industries, as these form significant end users for stem cell research products.
The continuation of this trend—the growth of the end-user base—has compelled a number of companies to launch new products and invest in stem cell-based therapies.
According to estimates from the Deloitte Touche Tohmatsu Limited (DTTL) Life Sciences and Health Care Industry Group, biotech drugs (vaccines, biologics) continue to gain traction in the life sciences sector.Of the top ten pharmaceutical products (by sales) in 2014, the majority were biotech drugs.
Biotech drug sales were estimated at USD 289 billion in 2014, and this figure is projected to grow to USD 445 billion by 2019.
Moreover, biotech drugs accounted for a share of 18% of the total sales of drugs in 2010, which is expected to increase to 26% by 2019.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47610330Ethical issues related to embryonic stem cell research Research in cell biology necessitates the use of animals and humans, as animal and human cells are used in gene therapy studies that involve the recombination of genes and stem cell research therapies.
These cells are also used for in vivo toxicity and pharmacokinetic testing of drugs that may harm animals and humans.In addition, stem cell research studies use human embryos for clinical applications that often lead to the destruction of the embryos.
Based on the products, the intelligent packaging market is segmented into corrosion control packaging, moisture control packaging, gas scavengers, QR code, susceptor packaging, and others.
The application basis of segmenting the intelligent packaging market consists of automotive, pharmaceuticals, food & beverages, electronics, and others.
The North American region is governing the principal portion of the global intelligent packaging market owing to the mounting demand for frozen and packaged food.
The weakening of trade channels is projected to present new challenges that have to be overcome expediently in the coming years.
The establishment of a definite competitive advantage is estimated to spur market development in the forecast period.
Donnelly Sons & Company (U.S.), Huhtamaki Group (Finland), American Thermal Instruments (U.S.), Thin Film Electronics ASA (Norway), Avery Dennison (U.S.), 3M (U.S.), International Paper (U.S.), Stora Enso (Finland), and Smartrac N.V. (The Netherlands), among others.Access Report Details @ https://www.marketresearchfuture.com/reports/intelligent-packaging-market-1999Industry Updates:Apr 2020 LivingPackets, a Franco-German logistics startup, has raised €5 million via a crowdfunding drive to expand its intelligent packaging system, THE BOX, which is intended to decrease shipping trash and develop last-mile delivery check.
